The 2019 Mass Spectrometry Market for Clinical Applications

13 Aug 2019

Global Site License

Mass spectrometry generally exists at the frontier of analytical measurement capabilities, continually driving innovation and growth for sensitive quantitative and qualitative laboratory testing worldwide. As noted in SDi’s coverage of the technology in the 2019 Global Assessment Report, its growth in the marketplace is primarily being driven from pharmaceuticals, foods, and environmental testing labs. Over the past decade, however, robust increase in demand from hospital and clinical labs has proven to be one of the greatest drivers of this technology. Moreover, there has been an explosion of sales in the world of in vitro diagnostics following the FDA clearance and CE-marking of select models and assays over the past few years.
The 2019 Mass Spectrometry Market for Clinical Applications provides a detailed view of the entire landscape of the clinical market for mass spectrometry (MS). Produced in collaboration with Kalorama Information, the report steps into the world of both clinical research and clinical diagnostics, looking at how the technology has been implemented into application areas such as toxicology, therapeutic drug monitoring, microbial identification, vitamin D quantitation, newborn screening, and more. Specifically, this report offers the following:
• Market size, product type segmentation with five-year market growth rate projection, and vendor share for 6 categories of MS instrumentation, with commentary
• For the overall clinical MS market, information is presented on market size, product type segmentation with five-year market growth rate projection, vendor share, application segmentation, and a comparison of the general MS market size to the clinical MS market size
• A timeline of government regulated IVD approved MS systems
• A timeline of recent MS product introductions relevant to the clinical field
• A timeline of recent collaborations among clinical MS suppliers
The way in which this report will be useful will vary depending on what information the reader is looking for and how they intend to use that information. Generally, this report should be useful to any organization or individual that finds value in receiving in-depth sales data on the clinical market for mass spectrometry that is both segmented and forecasted, gaining a clearer picture of supplier market share, and gauging the overall direction of future growth. This information is perhaps most useful in assisting current supplier companies and future supplier companies in the development of their internal market outlook and both short- and long-term marketing strategies.
 

Page Count: 76